There is a low diversification of 12 months returns within the 'Insurance'. The sector is around 14 percent higher since January. Among the winners we find Kodiak Sciences, Avita Medical and Silence Therapeutics. Relatively big losses are for Organogenesis Holdings, OpGen and Mologen AG.
The large caps in this sector are the winners. Among the less performing are mostly the smallcaps.
Regarding the price/earnings-ratios we see a uniform palette. The smallcaps are with the price/earnings-ratio of 17 the most expensive. The midcaps are the cheapest and trade at 13 times the earnings per share. Diaceutics, Abcam and Genus are the stocks with the highest ratios. Stocks with the lowest ratios are Assertio Therapeutics, Endo International and Lexicon Pharmaceuticals.
The sector's average dividend yield is with 3 percent relatively high. Stocks now high dividend yields now are Abbvie, Gilead Sciences and Bayer AG.
This is a free publication from Valuespectrum Pro. Valuespectrum Pro is a professional platform with analyses from all US and European companies. Click here to sign up for free.